References
1. Gutiérrez Castillo C, Monerris García E, Duran MD, Sancho Mestre M, Gras JR. Papilomas y papilomatosis laríngea. Tratamiento con láser CO2. Nuestra experiencia en 15 años. Acta Otorrinolaringológica Española . 2010;61(6):422–7.
2. Kim H-T, Baizhumanova AS. Is Recurrent Respiratory Papillomatosis a Manageable or Curable Disease? Laryngoscope . 2016;126(6):1359–64.
3. Maturo SC, Hartnick CJ. Juvenile-onset recurrent respiratory papillomatosis. Adv Otorhinolaryngol . 2012;73:105-8.
4. Valerie A , Vasiliki K E . Recurrent respiratory papillomatosis: An extensive review. Int J Hematol Stem Cell Res . 2012;6(3):19–28.
5. Ivancic R, Iqbal H, deSilva B, Pan Q, Matrka L. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol . 2018;3(1):22–34.
6. Kurita T, Chitose S-I, Sato K, et al. Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics.Laryngoscope Investig Otolaryngol . 2019;4(1):89–94.
7. Kim D, Siegel J, Chouake RJ, et al. Implication and Management of Incidental Oropharyngeal Papillomas-A Retrospective Case Series Review.Ear, Nose Throat J . 2019;145561319871228.
8. Wiatrak BJ. Overview of recurrent respiratory papillomatosis.Curr Opin Otolaryngol Head Neck Surg . 2003;11(6):433–41.
9. Lechien J R , Burns J A , Akst L M . The Use of 532-Nanometer-Pulsed Potassium-Titanyl- Phosphate (KTP) Laser in Laryngology: A Systematic Review of Current Indications, Safety, and Voice Outcomes. Ear, Nose Throat J . 2020;
10. Wei C S, Zhang P, HePJ. KTP laser treatment for recurrent laryngeal papilloma. 13th Natl Acad Conf Otolaryngol Neck Surg Chinese Med Assoc . 2014;202–3.
11. Dodhia S , Baxter P C , Ye F , et al., et al. Investigation of the presence of HPV on KTP laser fibers following KTP laser treatment of papilloma. Laryngoscope . 2018;128(4):926–8.
12. Florian P S, Peter K J, Jungehulsing M, Edmund E H, Guntinas-Lichius O, Damm M. Long-term results of surgical treatment for recurrent respiratory papillomatosis. Acta Otolaryngol . 2007;127(11):1196–201.
13. Toma S, Hudson K. Recurrent respiratory papillomatosis in the larynx: Postoperative web formation improves outcomes. Clin Otolaryngol . 2012;37(SUPPL. 1):121.
14. Motta G, Villari G, Motta G Jr, Ripa G, Salerno G. CO2 laser in laryngeal microsurgery. Int Surg . 1987;72(3):175–8.
15. Pratt LW.The CO2 laser in otolaryngology. J Maine Med Assoc . 1980;71(2):39–45.
16. Damm M, Eckel HE, Schneider D, Arnold G. CO2 laser surgery for verrucous carcinoma of the larynx. LASERS Surg Med . 1997;21(2):117–23.
17. Keane WM, Atkins JP Jr. CO2 laser surgery of the upper airway.Surg Clin North Am . 1984;64(1):955–71.
18. Wellenstein DJ, Honings J, Schimberg AS, et al. Office-based CO2 laser surgery for benign and premalignant laryngeal lesions.Laryngoscope . 2020;130(6):1503–7.
19. Strong MS, Vaughan CW, Cooperband SR, Healy GB, Clemente MA. Recurrent respiratory papillomatosis. Management with the CO2 laser.Ann Otol Rhinol Laryngol . 1976;85(4 I):508–16.
20. McMillan K, Shapshay SM, McGilligan JA, Wang Z, Rebeiz EE. Preliminary clinical results of pulsed dye laser therapy for recurrent respiratory papillomatosis. 1998. p. 182–90.
21. Valdez TA, McMillan K, Shapshay SM. A new laser treatment for vocal cord papilloma–585-nm pulsed dye. Otolaryngol neck Surg Off J Am Acad Otolaryngol Neck Surg . 2001;124(4):421–5.
22. McMillan K, Shapshay SM, McGilligan JA, Wang Z, Rebeiz EE.. A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: Preliminary report. Laryngoscope . 1998;108(7):968–72.
23. Abitbol J, Abitbol P. Pulse dye laser: Laryngeal microsurgical procedure by non-invasive laser surgery on outpatients about 57 cases.Lasers Surg Med . 2013;45(SUPPL. 25):67–8.
24. Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol . 1998;54(3):219–25.
25. Coulombeau B, Nusa Naiman A, Ceruse P, Froehlich P. [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].Rev Laryngol Otol Rhinol (Bord) . 2002;123(5):315–20.
26. Chhetri DK, Blumin JH, Shapiro NL, et al. Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir.Otolaryngol - Head Neck Surg . 2002;126(6):642–8.
27. Koufman J. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol . 2007;116(4):317.
28. Lechien JR, Burns JA, Akst LM. The Use of 532-Nanometer-Pulsed Potassium-Titanyl-Phosphate (KTP) Laser in Laryngology: A Systematic Review of Current Indications, Safety, and Voice Outcomes. Ear, Nose Throat J . 2021;100(1_suppl):4S-13S.
29. Xie X, Young J, Kost K, et al. KTP 532 nm laser for laryngeal lesions. A systematic review. J Voice . 2013;27(2):245–9.
30. Kaluskar SK, Mehta R, Farnan TB, Basha SI. Endoscopic 532-nm KTP laser excision of inverted papilloma of the nose and paranasal sinuses: a series of 9 patients. Ear Nose Throat J . 2009;88(4):880–7.
31. Hess M, Fleischer S. Photoangiolytic Lasers in Laryngology.Laryngorhinootologie . 2020;99(9):185–91.
32. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.Rev Esp Nutr Humana y Diet . 2014;18(3):172–81.
33. Hu H-C, Lin S-Y, Hung Y-T, Chang S-Y. Feasibility and Associated Limitations of Office-Based Laryngeal Surgery Using Carbon Dioxide Lasers. JAMA Otolaryngol Neck Surg. 2017;143(5):485.
34. Hung WC, Lo WC, Fang KM, et al. Longitudinal Voice Outcomes Following Serial Potassium Titanyl Phosphate Laser Procedures for Recurrent Respiratory Papillomatosis. Ann Otol Rhinol Laryngol . 2020;130(4):363–9.
35. Burns JA, Zeitels SM, Akst LM, et al. 532 nm pulsed potassium-titanyl-phosphate laser treatment of laryngeal papillomatosis under general anesthesia. Laryngoscope . 2007;117(8):1500–4.
36. Saleh EM. Complications of treatment of recurrent laryngeal papillomatosis with the carbon dioxide laser in children. J Laryngol Otol . 1992;106(8):715–8.
37. Robb PJ. The C0 2 laser and management of recurrent laryngeal papilloma: The Guy’s experience by. J Laryngol Otol . 1987;101(4):369–75.
38. Mattot M, Ninane J, Hamoir M, et al. Combined C02-Laser and Alfa Recombinant Interferon Treatment in Five Children with Juvenile Laryngeal Papillomatosis. Acta Clin Belg . 1990;45(3):158–63.
39. Holler T, Allegro J, Chadha NK, et al. Voice Outcomes Following Repeated Surgical Resection of Laryngeal Papillomata in Children.Otolaryngol Neck Surg . 2009;141(4):522–6.
40. Dedo HH, Yu KCY. CO2 Laser Treatment in 244 Patients With Respiratory Papillomas. Laryngoscope . 2001;111(9):1639–44.
41. Araki K, Tomifuji M, Uno K, et al. Feasibility of transnasal flexible carbon dioxide laser surgery for laryngopharyngeal lesions.Auris Nasus Larynx . 2019;46(5):772–8.
42. Dedo HH, Jackler RK. Laryngeal Papilloma: Results of Treatment with the CO 2 Laser and Podophyllum. Ann Otol Rhinol Laryngol . 1982;91(4):425–30.
43. Hu HC, Lin SY, Hung YT, Chang SY. Feasibility and Associated Limitations of Office-Based Laryngeal Surgery Using Carbon Dioxide Lasers. JAMA Otolaryngol Neck Surg . 2017;143(5):485.
44. Liu F, Shi L, Ji WY. 22 cases of laryngeal papilloma treated with potassium titanium phosphate laser. J Clin Otorhinolaryngol Head Neck Surg . 2005;01(18):1001–781.
45. Best SR, Esquivel D, Mellinger-Pilgrim R, Roden RBS, Pitman MJ. Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts. Laryngoscope . 2020;130(3):712–7.
46. Best SR, Esquivel D, Mellinger-Pilgrim R, Roden RBS, Pitman MJ. Nasopharyngeal papillomas treated with CO2 laser and human papillomavirus vaccination. Laryngoscope . 2017;127(10):2279–81.
47. Ilmarinen T, Auvinen E, Hiltunen-Back E, et al. Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts. Eur Arch Oto-Rhino-Laryngology . 2012;269(11):2367–71.
48. Snoeck R, Wellens W, Desloovere C, et al. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Clin Otolaryngol Off J ENT-UK ; Off J Netherlands Soc Oto-Rhino-Laryngology Cerv-fac Surg . 2015;11(3):221–4.
49. Fortes HR, von Ranke FM, Escuissato DL, et al. Recurrent respiratory papillomatosis: A state-of-the-art review. Respir Med . 2017;126:116–21.
50. San Giorgi MRM, van den Heuvel ER, Tjon Pian Gi REA, et al. Age of onset of recurrent respiratory papillomatosis: a distribution analysis.Clin Otolaryngol Off J ENT-UK ; Off J Netherlands Soc Oto-Rhino-Laryngology Cerv-fac Surg . 2016;41(5):448–53.
51. Maïga S, Ndiaye C, Diouf MS, et al. Laryngeal papillomatosis in Senegal: A ten-year experience. Eur Ann Otorhinolaryngol NECK Dis . 2018;135(3):221–4.
52. Kin Cho Goon P, Scholtz LU, Sudhoff H. Recurrent respiratory papillomatosis (RRP)-time for a reckoning? Laryngoscope Investig Otolaryngol . 2017;2(4):184–6.
53. Tu YP, Jennings R, Hart B, et al. Therapeutic use of the HPV vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis Rosenberg. Journals Gerontol Ser A Biol Sci Med Sci . 2018;0813(April):1–11.
54. Scatolini ML, Labedz G, Cocciaglia A, et al. Laryngeal sequelae secondary to surgical treatment for recurrent respiratory papillomatosis in children. Int J Pediatr Otorhinolaryngol . 2020;130:109815.
55. Nielsen NR, Rasmussen N, N.R. N. Laryngeal papillomatosis treated with CO2 laser. Ugeskr Laeger . 2010;172(4):284–9.
56. Halum SL, Moberly AC. Patient tolerance of the flexible CO2 laser for office-based laryngeal surgery. J voice . 2010;24(6 CC-ENT):750–4.
57. Saleh EM. Complications of treatment of recurrent laryngeal papillomatosis with the carbon dioxide laser in children. J Laryngol Otol . 1992;106(8):715–8.
58. Hirano, Minoru. Clinical Examination of Voice by Minoru Hirano.J Acoust Soc Am . 1986;80(4):1273.
59. Koufman J, Zeitels SM, Akst LM, et al. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol . 2006;115(9 I):679–85.